Sebastian J. Padayatty et al., 2004-04-06: NIH pharmacokinetic study in 17 healthy volunteers plus modelling, showing that oral vitamin C concentrations are tightly controlled while a 50 g intravenous dose predicts plasma concentrations some 60-fold higher (13,400 vs 220 micromol/L).
only intravenous administration of vitamin c produces high plasma and urine concentrations that might have antitumor activity
Conclusions, unpaginated web record
Sebastian J. Padayatty et al., 2004-04-06: NIH pharmacokinetic study in 17 healthy volunteers plus modelling, showing that oral vitamin C concentrations are tightly controlled while a 50 g intravenous dose predicts plasma concentrations some 60-fold higher (13,400 vs 220 micromol/L). Funder: NIH intramural research (NIDDK). Maker: pharmaceutical-grade ascorbic acid, no commercial sponsor. Comparator: dose-ranging within subjects, oral versus intravenous. Conflicts: none declared. This paper supports the book's factual point that IV vitamin C reaches far higher blood levels than oral, and simultaneously explains why the oral-only Mayo trials could not have tested the high-dose hypothesis – it does not show clinical benefit, and the authors call for re-evaluation, not endorsement. The abstract itself lowercases 'vitamin c'; quoted as published.
